Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zura Bio Ltd | Director | Class A ordinary shares | 777K | $2.43M | $3.13 | Apr 22, 2024 | Direct |
Zura Bio Ltd | Director | Class A ordinary shares | 777K | $2.43M | $3.13 | Apr 22, 2024 | Direct |
Inhibikase Therapeutics, Inc. | Director | Common Stock | 365K | $500K | $1.37 | Oct 21, 2024 | By Amit Munshi Revocable Trust |
Inhibikase Therapeutics, Inc. | Director | Stock Option (right to buy) | 60K | Oct 21, 2024 | Direct | ||
Galecto, Inc. | Director | Stock Option (right to buy) | 18K | Jun 20, 2024 | Direct | ||
ARENA PHARMACEUTICALS INC | President and CEO, Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
ARENA PHARMACEUTICALS INC | President and CEO, Director | Employee Performance Restricted Stock Unit | 0 | Mar 11, 2022 | Direct | ||
ARENA PHARMACEUTICALS INC | President and CEO, Director | Employee Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics, Inc. | Oct 21, 2024 | 2 | $500K | 4 | Oct 23, 2024 | Director |
IKT | Inhibikase Therapeutics, Inc. | Oct 21, 2024 | 0 | $0 | 3 | Oct 23, 2024 | Director |
GLTO | Galecto, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
ZURA | Zura Bio Ltd | Apr 22, 2024 | 1 | $500K | 4/A | Sep 6, 2024 | Director |
GLTO | Galecto, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
ZURA | Zura Bio Ltd | Jun 5, 2023 | 1 | $500K | 4 | Jun 5, 2023 | Director |
ZURA | Zura Bio Ltd | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
ZURA | Zura Bio Ltd | Mar 20, 2023 | 0 | $0 | 3 | Mar 21, 2023 | Director |
GLTO | Galecto, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
ARNA | ARENA PHARMACEUTICALS INC | Mar 11, 2022 | 11 | -$1.03M | 4 | Mar 11, 2022 | President and CEO, Director |
ARNA | ARENA PHARMACEUTICALS INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | President and CEO, Director |
ARNA | ARENA PHARMACEUTICALS INC | Aug 16, 2021 | 1 | $48.2K | 4 | Aug 17, 2021 | President and CEO, Director |
ARNA | ARENA PHARMACEUTICALS INC | Aug 12, 2021 | 1 | $50.4K | 4 | Aug 13, 2021 | President and CEO, Director |
ARNA | ARENA PHARMACEUTICALS INC | Aug 10, 2021 | 1 | $52.9K | 4 | Aug 11, 2021 | President and CEO, Director |
DNAD | Social Capital Suvretta Holdings Corp. IV | Jun 29, 2021 | 0 | $0 | 3 | Jun 29, 2021 | Director |